Carcinoma matrix controls resistance to cisplatin through talin regulation of NF-kB.
Extracellular matrix factors within the tumor microenvironment that control resistance to chemotherapeutics are poorly understood. This study focused on understanding matrix adhesion pathways that control the oral carcinoma response to cisplatin. Our studies revealed that adhesion of HN12 and JHU012...
Main Authors: | Karen E Eberle, Hope A Sansing, Peter Szaniszlo, Vicente A Resto, Allison L Berrier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3123362?pdf=render |
Similar Items
-
The Links between ALS and NF-kB
by: Emma Källstig, et al.
Published: (2021-04-01) -
Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
by: Frontiers Editorial Office
Published: (2021-06-01) -
Targeting NF-kB Signaling for Multiple Myeloma
by: Ada Hang-Heng Wong, et al.
Published: (2020-08-01) -
Cloning and expression of equine NF-kB2
by: Mirhosseini, Negin
Published: (2010) -
Involvement of NF-kB in fear potentiated startle
by: Shiu-Hwa Yeh, et al.
Published: (2005)